Medartis Holding AGXSWX:MED +4.28%79 EV-to-FCF is 120.47 as of Jun. 27, 2026, which is 191% above its 10-year median of 41.43. GuruFocus rates XSWX:MED with a GF Score™ of 79/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 421 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 87.65% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medartis Holding AG's Enterprise Value is CHF1,125.4 Mil.
Medartis Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF9.3 Mil. Therefore, Medartis Holding AG's EV-to-FCF for today is 120.47.
The historical rank and industry rank for Medartis Holding AG's EV-to-FCF or its related term are showing as below:
XSWX:MED'
s EV-to-FCF Range Over the Past 10 Years
Min: -3265.16 Med: 41.43 Max: 937.5
Current: 112.08
During the past 12 years, the highest EV-to-FCF of Medartis Holding AG was 937.50. The lowest was -3265.16. And the median was 41.43.
XSWX:MED's EV-to-FCF is ranked worse than 87.65% of 421
companies
in the Medical Devices & Instruments industry
Industry Median: 22.82
vs XSWX:MED: 112.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medartis Holding AG (XSWX:MED) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medartis Holding AG's PE Ratio (TTM) for today is calculated as:
Medartis Holding AG's share price for today is CHF80.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.670.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medartis Holding AG EV-to-FCF Related Terms
Medartis Holding AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's EV-to-FCF falls into.
Medartis Holding AG's current Enterprise Value is CHF1,125.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medartis Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was CHF9.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a EV-to-FCF of 120.47 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medartis Holding AG and its competitors. This is 191% above median its historical median of 41.43. According to the industry distribution chart, Medartis Holding AG ranks #369 out of 421 companies in the Medical Devices & Instruments industry, placing it in the top 87.6%.
Is Medartis Holding AG's EV-to-FCF too high?
Medartis Holding AG's current EV-to-FCF of 120.47 is 191% above median its 10-year median of 41.43. The Medical Devices & Instruments industry median EV-to-FCF is 22.82. Medartis Holding AG's value of 120.47 is 427.9% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #369 out of 421 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medartis Holding AG has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #369 out of 421 companies for EV-to-FCF. This places Medartis Holding AG in the lower half of its industry. The industry median EV-to-FCF is 22.82. Medartis Holding AG's value of 120.47 is 427.9% above this benchmark. While the company's 10-year median is 41.43 vs. the industry median of 22.82, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.82, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current EV-to-FCF of 120.47 is 427.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current EV-to-FCF is 120.47, which is 191% above median its own 10-year median of 41.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF80.40 — trading 23.9% below its estimated fair value. The current EV-to-FCF is 120.47, which is 191% above median its 10-year median of 41.43 and 427.9% above the Medical Devices & Instruments industry median of 22.82. Medartis Holding AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current EV-to-FCF is 120.47 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF80.40 is trading 23.9% below its estimated GF Value™ of CHF105.66.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
EV-to-FCF: 120.47 (191% above median its 10-year median of 41.43)
GF Value™: CHF105.66 vs. price of CHF80.40 (23.9% below fair value)
Industry Position: 427.9% above the Medical Devices & Instruments median (#369 of 421)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
79GF Score
Get the complete analysis for XSWX:MED
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
